Viewing Study NCT00461058


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2025-12-25 @ 9:59 PM
Study NCT ID: NCT00461058
Status: COMPLETED
Last Update Posted: 2016-08-05
First Post: 2007-04-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module